Endothelial-dependent vasorelaxation was significantly blunted in groups that received AF- versus PF-FMT groups (Fig
The conversation How much weight do you want to lose
Research suggests it may increase growth hormone production between 200-1000%
Serving patients in Narangba, Burpengary, Dakabin, Deception Bay, Morayfield, North Lakes and North Brisbane surrounds
Start retatrutide at a low dose and titrate
Compound Receptors Peak trial weight loss Lean mass as share of loss Semaglutide (Ozempic/Wegovy) GLP-1 ~14.9% (STEP-1, 68 wk) ~39% Tirzepatide (Mounjaro/Zepbound) GLP-1 + GIP ~20.9% (SURMOUNT-1, 72 wk) ~25-40% Retatrutide GLP-1 + GIP + GCGR ~24.2% (Phase 2, 48 wk) Comparable class range Best for understanding the takeaway: the percentage of loss that is lean mass is roughly constant across the class